Cargando…

812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?

BACKGROUND: Soil-associated Mucorales fungi frequently host bacterial endosymbionts that produce damaging endotoxins important for plant pathology. Our work and clinical reports suggest an important and unanticipated role for endosymbionts in human disease. The endosymbiont Mycetohabitants rhizoxini...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon, Dora Edith Corzo, Harrison, Jamie, Uehling, Jessie, López-Jácome, Luis Esaú, Borman, Andy, Ballou, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678752/
http://dx.doi.org/10.1093/ofid/ofad500.857
_version_ 1785150438238060544
author Leon, Dora Edith Corzo
Harrison, Jamie
Uehling, Jessie
López-Jácome, Luis Esaú
Borman, Andy
Ballou, Elizabeth
author_facet Leon, Dora Edith Corzo
Harrison, Jamie
Uehling, Jessie
López-Jácome, Luis Esaú
Borman, Andy
Ballou, Elizabeth
author_sort Leon, Dora Edith Corzo
collection PubMed
description BACKGROUND: Soil-associated Mucorales fungi frequently host bacterial endosymbionts that produce damaging endotoxins important for plant pathology. Our work and clinical reports suggest an important and unanticipated role for endosymbionts in human disease. The endosymbiont Mycetohabitants rhizoxinica was associated with bacteriemia in an immunocompromised individual where its host Rhizopus microsporus caused mucormycosis. Our data demonstrate the endosymbiont Ralstonia pickettii can impact virulence of its R. microsporus host. Together, these data suggest Mucorales endosymbionts can influence both fungal and bacterial infections; however, their frequency and diversity in Mucormycosis is unknown. This project investigates the frequency and diversity of bacterial endosymbionts in Mucorales clinical isolates. METHODS: Mucorales isolates from mucormycosis patients via the UK National Mycology Reference Laboratory and the Instituto Nacional de Rehabilitacion, Mexico, were identified by ITS1/2 PCR or MALDI-TOF. Fungal isolates (YPG agar, 5 days, 30 (o)C) were subjected to phenol/chloroform DNA extraction. Bacterial presence was assessed by 16s RNA PCR, and resulting bands identified by nanopore sequencing. In parallel, WGS of total DNA confirmed bacterial presence and identity. Bacteria were also physically isolated from homogenized fungal mycelia (nutrient broth, 80rpm, 37(o)C, 4 days) harvested under sterile conditions. Bacteria from supernatants (LB, Blood agar, 30 and 37 (o)C ± 5% CO(2), 4-10 days) were identified by 16s RNA PCR and Nanopore sequencing. RESULTS: In total, 27 Mucorales isolates (R. arrhizus/delemar n=7; R. microsporus n=6; Lichtheimia corymbifera n=4; L. ramosa n=3; Mucor circinelloides n=4; others n=3) were evaluated for bacteria presence. 17/27 (62%) were 16s RNA positive. Culture identified 6 bacterial species (R. pickettii, Niallia circulans, Peribacillus simplex, Roseomonas mucosa, Micrococcus luteus, Staphylococcus pasteuri). Mucorales isolates originated from cutaneous 11/27 (41%); respiratory 8/27 (29%); and sinus-orbital diseases 7/27 (26%). CONCLUSION: The presence of bacterial endosymbionts in clinical isolates of Mucorales is frequent, diverse and can potentially influence fungi in causing disease among individuals at risk. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678752
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106787522023-11-27 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis? Leon, Dora Edith Corzo Harrison, Jamie Uehling, Jessie López-Jácome, Luis Esaú Borman, Andy Ballou, Elizabeth Open Forum Infect Dis Abstract BACKGROUND: Soil-associated Mucorales fungi frequently host bacterial endosymbionts that produce damaging endotoxins important for plant pathology. Our work and clinical reports suggest an important and unanticipated role for endosymbionts in human disease. The endosymbiont Mycetohabitants rhizoxinica was associated with bacteriemia in an immunocompromised individual where its host Rhizopus microsporus caused mucormycosis. Our data demonstrate the endosymbiont Ralstonia pickettii can impact virulence of its R. microsporus host. Together, these data suggest Mucorales endosymbionts can influence both fungal and bacterial infections; however, their frequency and diversity in Mucormycosis is unknown. This project investigates the frequency and diversity of bacterial endosymbionts in Mucorales clinical isolates. METHODS: Mucorales isolates from mucormycosis patients via the UK National Mycology Reference Laboratory and the Instituto Nacional de Rehabilitacion, Mexico, were identified by ITS1/2 PCR or MALDI-TOF. Fungal isolates (YPG agar, 5 days, 30 (o)C) were subjected to phenol/chloroform DNA extraction. Bacterial presence was assessed by 16s RNA PCR, and resulting bands identified by nanopore sequencing. In parallel, WGS of total DNA confirmed bacterial presence and identity. Bacteria were also physically isolated from homogenized fungal mycelia (nutrient broth, 80rpm, 37(o)C, 4 days) harvested under sterile conditions. Bacteria from supernatants (LB, Blood agar, 30 and 37 (o)C ± 5% CO(2), 4-10 days) were identified by 16s RNA PCR and Nanopore sequencing. RESULTS: In total, 27 Mucorales isolates (R. arrhizus/delemar n=7; R. microsporus n=6; Lichtheimia corymbifera n=4; L. ramosa n=3; Mucor circinelloides n=4; others n=3) were evaluated for bacteria presence. 17/27 (62%) were 16s RNA positive. Culture identified 6 bacterial species (R. pickettii, Niallia circulans, Peribacillus simplex, Roseomonas mucosa, Micrococcus luteus, Staphylococcus pasteuri). Mucorales isolates originated from cutaneous 11/27 (41%); respiratory 8/27 (29%); and sinus-orbital diseases 7/27 (26%). CONCLUSION: The presence of bacterial endosymbionts in clinical isolates of Mucorales is frequent, diverse and can potentially influence fungi in causing disease among individuals at risk. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678752/ http://dx.doi.org/10.1093/ofid/ofad500.857 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Leon, Dora Edith Corzo
Harrison, Jamie
Uehling, Jessie
López-Jácome, Luis Esaú
Borman, Andy
Ballou, Elizabeth
812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title_full 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title_fullStr 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title_full_unstemmed 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title_short 812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
title_sort 812. bacterial endosymbionts are frequently found among mucorales clinical isolates. should we screen for their presence in patients with mucormycosis?
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678752/
http://dx.doi.org/10.1093/ofid/ofad500.857
work_keys_str_mv AT leondoraedithcorzo 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis
AT harrisonjamie 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis
AT uehlingjessie 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis
AT lopezjacomeluisesau 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis
AT bormanandy 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis
AT ballouelizabeth 812bacterialendosymbiontsarefrequentlyfoundamongmucoralesclinicalisolatesshouldwescreenfortheirpresenceinpatientswithmucormycosis